Maxigen Biotech (TPE:1783) Long-Term Debt : NT$0.0 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Long-Term Debt?

Maxigen Biotech's Long-Term Debt for the quarter that ended in Mar. 2025 was NT$0.0 Mil.

Maxigen Biotech Long-Term Debt Historical Data

The historical data trend for Maxigen Biotech's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Long-Term Debt Chart

Maxigen Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

Maxigen Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Maxigen Biotech (TPE:1783) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Maxigen Biotech Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333

Website

https://www.mbi-bio.com

Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.

Maxigen Biotech Headlines

No Headlines